Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Microbot Medical Inc

MBOT
Current price
0.95 USD -0.0032 USD (-0.34%)
Last closed 0.95 USD
ISIN US59503A2042
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 16 669 483 USD
Yield for 12 month -33.37 %
1Y
3Y
5Y
10Y
15Y
MBOT
21.11.2021 - 28.11.2021

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts. Address: 288 Grove Street, Braintree, MA, United States, 02184

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-106 000 USD

Last Year

-102 000 USD

Current Quarter

-14 000 USD

Last Quarter

-28 000 USD

Key Figures MBOT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -9 410 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -64.88 %
PEG Ratio
Return On Equity TTM -134.46 %
Wall Street Target Price 7 USD
Revenue TTM
Book Value 0.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.78 USD
Diluted Eps TTM -0.78 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MBOT

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MBOT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:15
Payout Ratio
Last Split Date 05.09.2018
Dividend Date 05.09.2018

Stock Valuation MBOT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -0.888
Price Book MRQ 2.6625

Financials MBOT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MBOT

For 52 weeks

0.82 USD 2.23 USD
50 Day MA 0.94 USD
Shares Short Prior Month 319 099
200 Day MA 1.07 USD
Short Ratio 2.17
Shares Short 390 237
Short Percent 2.42 %